Al Ti Global, Inc. Genenta Science S.P.A. Transaction History
Al Ti Global, Inc.
- $4.26 Trillion
- Q3 2025
A detailed history of Al Ti Global, Inc. transactions in Genenta Science S.P.A. stock. As of the latest transaction made, Al Ti Global, Inc. holds 200,288 shares of GNTA stock, worth $440,633. This represents 0.01% of its overall portfolio holdings.
Number of Shares
200,288
Previous 200,288
-0.0%
Holding current value
$440,633
Previous $791 Million
19.49%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding GNTA
# of Institutions
7Shares Held
552KCall Options Held
0Put Options Held
0-
Allianz Se Munich, 2M234KShares$514,9100.02% of portfolio
-
Algebris (Uk) LTD London, X0100KShares$220,0000.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.5KShares$27,4690.0% of portfolio
-
National Bank Of Canada3KShares$6,6000.0% of portfolio
-
Morgan Stanley New York, NY2.2KShares$4,8400.0% of portfolio
About Genenta Science S.p.A.
- Ticker GNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,216,900
- Market Cap $40.1M
- Description
- Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated...